The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Looks like the market has taken Carls departure totally in its stride.
Price still below pre FDA approval prices. I remember watching a Proactive Investors video end of last year, where a board member stated the price had dropped to 160 and this would be a good entry point ! Jeepers , what are we at now. Bargin shares are us !
What you would be able to see during these trials is the comparison of patients in the trial, to those who are not..
ie if there were 20 on a ward. 10 in trial. thus 5 SNG001 and 5 placebo. 10 not involved..you could surely see if a higher percentage of the 10 IN the trial were improving....
Very simplistic view I know
You would also see if loads in the test were deteriorating/dying. in which case you would halt surely ?
Good points Shandy.
TBF. Carl seemed good in his presentations etc, but perhaps he wasn’t a great CEO. The share price went from 180 to 50 for no good reason ( in my eyes). You could thus say the CEO was not doing a great job for the company and shareholders alike. Like a
Premiership manager with a great team but not getting results.
The H2H was a minor point.
R Griffiths sold loads ( has done in a few companies recently )
Covid 19 share panic.
All contributed to the fall. But the CEO has to share the blame.
But still the company is way undervalued IMO.
Well , always strange when a CEO moves on.
That’s business though.
US deal still going with which he is helping so no sour grapes and obviously US deal happening.
And no reflection on product.
Derisked product for multi billion dollar industry
GLA
People are going to get left behind here if they are out. Relatively low number of shares in PI hands, so non available. Holders know this should be back at 170/180 levels as previous.... plus upsides ( US deal , probable fall in IV delivery )
GLA
DYOR
Interferon beta is safe. That’s been show and won’t be an issue. The issue is if it helps the lungs as expected. The money and knowledge say yes. The day traders and PIs trying to make a few quid may think it , but their actions stop a gradual price rise.
The unfortunate thing is , the rapid rise brings in day traders. As a long term holder hard to watch the dips. As you do when your share is rising. You just have to remember no share rises in a straight line. Let the day traders do their thing. Long term holders know where we are heading.
I’ve read masses of treatments for Covid 19. THIS IS THE MOST PROMISING. On top of that we have prophylactic use. Stock piling potential for future viral pandemics, And everyday use for COOD / Asthma uses. These opportunities don’t come that often.
And yes I’m glad I’m holding !